SCHEMBL30075720

SCHEMBL30075720

CC1CCCCN1c1ccc(C(F)(F)F)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.47
MAOB P27338 1/20 0.47
AR P10275 1/20 0.46
PDK2 Q15119 1/20 0.44
GPBAR1 Q8TDU6 1/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
CNR2 P34972 2/20 0.40
CYP2C8 P10632 1/20 0.40
CYP2D6 P10635 1/20 0.40
CNR1 P21554 1/20 0.40
CYP2C19 P33261 1/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
NOTUM Q6P988 1/20 0.40
HSD11B1 P28845 1/20 0.40
TRPV1 Q8NER1 1/20 0.39
CHRM4 P08173 2/20 0.39
BCHE P06276 1/20 0.39
ACHE P22303 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16480461 0.95 AR (0.50) MAOAMAOBARPDK2MEN1
SCHEMBL12089288 0.82 MAOB (0.46) MAOAMAOBARPDK2MEN1
SCHEMBL13695438 0.79 ACHE (0.47) MAOAMAOBARPDK2MEN1
SCHEMBL26326852 0.79 MAOA (0.51) MAOAMAOBMEN1KMT2AKDM4E
SCHEMBL26326850 0.79 MAOA (0.51) MAOAMAOBMEN1KMT2AKDM4E
SCHEMBL5434382 0.77 MAPT (0.50) MAOAMAOBGPBAR1MEN1KMT2A
SCHEMBL16254933 0.77 PSEN1 (0.51) MAOAMAOBCNR2CNR1ALDH1A1
SCHEMBL3567064 0.77 ALDH1A1 (0.54) MAOAMAOBMEN1KMT2AKDM4E
SCHEMBL22816347 0.77 MAOA (0.50) MAOAMAOBARPDK2MEN1
SCHEMBL6748757 0.77 MAOA (0.50) MAOAMAOBARPDK2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11787798-B2 Aryl piperidines as monoacylglycerol lipase modulators JANSSEN PHARMACEUTICA NV (BE) 2023-10-17 US disclosed
US-20220363679-A1 ARYL PIPERIDINES AS MONOACYLGLYCEROL LIPASE MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2022-11-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11787798-B2 Aryl piperidines as monoacylglycerol lipase modulators MGLL, LPL, PNLIP MAOA 22/4885MAOB 25/4885AR 745/4885
US-20220363679-A1 ARYL PIPERIDINES AS MONOACYLGLYCEROL LIPASE MODULATORS MGLL, LPL, PNLIP MAOA 22/4885MAOB 25/4885AR 745/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.